Financhill
Back

ProShares UltraShort Nasdaq Biotech Vs. Trinet Group Industry Stock Comparison

Sell
20

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
17.59
Seasonality Move:
-10.36%
Sell
19

TNET
Trinet Group

Last Price:
102.78
Seasonality Move:
14.31%
Sell
20
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?

  • The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $17.59. The Score for BIS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
19
Trinet Group (TNET) is a Sell

Is Trinet Group a Buy, Sell or Hold?

  • The current Trinet Group [TNET] share price is $103.92. The Score for TNET is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • TNET is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BIS Stock Price Chart

What is ProShares UltraShort Nasdaq Biotech's stock price today?

  • The ProShares UltraShort Nasdaq Biotech share price today is $17.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing slight buying pressure.

TNET Stock Price Chart

What is Trinet Group's stock price today?

  • The Trinet Group share price today is $103.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TNET is experiencing slight buying pressure.

BIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 38.43 Sell
Chaikin Money Flow: 580 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.93 - 20.33) Sell
Bollinger Bands (100): (17.19 - 19.11) Sell

TNET Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.69 Sell
Relative Strength Index (14 RSI): 35.01 Sell
Chaikin Money Flow: 19284 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.59 - 124.23) Sell
Bollinger Bands (100): (110.21 - 129.43) Sell

BIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.86 Sell
20-day SMA: 18.77 Sell
50-day SMA: 18.66 Sell
200-day SMA: 20.25 Sell
8-day EMA: 17.84 Sell
20-day EMA: 18.4 Sell
50-day EMA: 18.62 Sell
200-day EMA: 19.59 Sell

TNET Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 102.76 Buy
20-day SMA: 107.87 Sell
50-day SMA: 120.64 Sell
200-day SMA: 116.09 Sell
8-day EMA: 103.36 Buy
20-day EMA: 108.01 Sell
50-day EMA: 115.45 Sell
200-day EMA: 113.46 Sell

ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Trinet Group Earnings Growth & TNET Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.12 per share, a decrease this year of $1.52 per share, and an increase next year of $0.83 per share.

ProShares UltraShort Nasdaq Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Trinet Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):